Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

Full description

Bibliographic Details
Main Authors: Carmine D'Aniello, Massimiliano Berretta, Carla Cavaliere, Sabrina Rossetti, Bianca Arianna Facchini, Gelsomina Iovane, Giovanna Mollo, Mariagrazia Capasso, Chiara Della Pepa, Laura Pesce, Davide D'Errico, Carlo Buonerba, Giuseppe Di Lorenzo, Salvatore Pisconti, Ferdinando De Vita, Gaetano Facchini
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
biomarkers
angiogenesis
immunotherapy
prognosis
renal cell carcinoma
targeted therapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01400/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01400/full

Similar Items